Published on 26 Dec 2024 on Benzinga
An endorsement of a weight-loss drug by world's richest man Elon Musk could prove beneficial in the battle between two health care companies seeing revenue growth and soaring stock prices as interest in weight-loss drugs grows.
What Happened: A post from Musk on Christmas shared his latest take on weight-loss drugs and could provide a suggestion to anyone trying to decide between Eli Lilly's LLY Mounjaro and Novo Nordisk's NVO Ozempic for weight-loss treatment.